Коморбидность хронической боли и депрессии у неврологических больных
https://doi.org/10.14412/2074-2711-2013-2332
Аннотация
Представлен обзор литературы, посвященной сочетанию хронических болевых синдромов и депрессии. Хроническая боль и депрессия оказывают взаимное влияние на клиническую манифестацию, течение и эффективность лечения у таких пациентов. При наличии множества неврологических, соматических и вегетативных расстройств, характерных для сочетания боли и депрессии, важное значение приобретает понимание природы этой коморбидности, а также ее диагностики и приоритетов в лечении. Сложность выявления собственно аффективной симптоматики у таких пациентов определяет менее благоприятные исходы, персистирующее течение хронической боли, развитие терапевтической резистентности и риск рецидивирования заболевания. Обсуждаются вопросы эпидемиологии, особенности клинических проявлений хронической боли и депрессии при наиболее распространенных неврологических заболеваниях. Рассматриваются современные концепции патогенеза коморбидности хронической боли и депрессии, вопросы психофармакологии.
Об авторе
Gyuzel Rafkatovna TabeevaРоссия
Список литературы
1. <div><p>Ayso-Mateos JL, Vazquez-Barquez JL, Dowrick C et al. Depressive disorders in Europe: prevalence figures from the ODIN study. Br J Psychiatr. 2001;179:308–16. DOI: 10.1192%2Fbjp.179.4.308.</p><p>Garcia-Cebrian A, Gandhi P, Demyttenaere K, Peveler R. The association of depression and painful physical symptoms - a review of European literature. Eur Psychiatry. 2006;21(6):379–88. DOI: 10.1016%2Fj.eurpsy.2005.12.003. Epub 2006 Jun 23.</p><p>Katona C, Peveler R, Dowrick C et al. Pain symptoms in depression: definition and clinical significance. Clin Med. 2005;5(4):390–5. DOI: 10.7861%2Fclinmedicine.5-4-390.</p><p>Дамулин ИВ. Особенности депрессии при неврологических заболеваниях. Журнал неврологии и психиатрии им. С.С.Корсакова. 2005;(10):55–6. [Damulin IV. Osobennosti depressii pri nevrologicheskikh zabolevaniyakh. Zhurnal nevrologii i psikhiatrii im. S.S.Korsakova. 2005;(10):55–6.]</p><p>Мосолов СН, Костюкова ЕГ, Городничев АВ и др. Клиническая эффективность и переносимость препарата эсциталопрам при лечении умеренной и тяжелой депрессии. Современная терапия психических расстройств. 2007;(2):42–7. [Mosolov SN, Kostyukova EG, Gorodnichev AV i dr. Klinicheskaya effektivnost' i perenosimost' preparata estsitalopram pri lechenii umerennoy i tyazheloy depressii. Sovremennaya terapiya psikhicheskikh rasstroystv. 2007;(2):42–7.]</p><p>Ustin T, Sartorius N. Preventive Services Task Forse: Guide to Clinical Preventive Services. 2nd ed. Washington, DC:US. Department of Health and Human Services; 1999.</p><p>Павленко СС, Тов НЛ. Исследование распространенности основных видов хронических болевых синдромов среди населения Новосибирска. Боль. 2003;(1):13–6. [Pavlenko SS, Tov NL. Issledovanie rasprostranennosti osnovnykh vidov khronicheskikh bolevykh sindromov sredi naseleniya Novosibirska. Bol'. 2003;(1):13–6.]</p><p>Воробьева ОВ. Клинические особенности депрессии в общемедицинской практике (по результатам программы «Компас»). Consilium Medicum. 2004;6(2):154–15. [Vorob'eva OV. Klinicheskie osobennosti depressii v obshchemeditsinskoy praktike (po rezul'tatam programmy «Kompas»). Consilium Medicum. 2004;6(2):154–15.]</p><p>Aguera L, Failde I, Cervilla JA et al. Medically unexplained pain complaints are associated with underlying unrecognized mood disorders in primary care. BMC Fam Pract. 2010;(11):17. DOI: 10.1186/1471-2296-11-17.</p><p>Ohayon MM. Specific Characteristics of the pain/depression association in the general population. J Clin Psychiatry. 2004;65 suppl 12:5–9.</p><p>Rijavec N, Grubic VN. Depression and pain: often together but still a clinical challenge – a review. Psychiatr Danub. 2012;24(4):346–52.</p><p>Geerlings SW, Twisk JW, Beekman AT et al. Longitudinal relationship between pain and depression in older adults: sex, age and pain disability. Soc Psychiatry Psychiatr Epidemiol. 2002;37(1):23–30. DOI: 10.1007%2Fs127-002-8210-2.</p><p>Robinson MJ, Edwards SE, Iyengar S et al. Depression and pain. Front Biosci (Landmark Ed). 2009;14:5031–51. DOI: 10.2741%2F3585.</p><p>Katon W. Panic disorder and somatization. Review of 55 cases. Am J Med. 1984;77:101–6.</p><p>Bair M, Robinson R, Katon W, Kroenke K. Depression and pain comorbidity: a literature review. Arch Intern Med. 2003;163(20):2433–45. DOI: 10.1001%2Farchinte.163.20.2433.</p><p>Husain MM, Rush AJ, Trivedi MH et al. Pain in depression: STAR*D study findings. J Psychosom Res. 2007;63(2):113–22. DOI: 10.1016%2Fj.jpsychores.2007.02.009.</p><p>Gureje O. Psychiatric aspects of pain. Curr Opin Psychiatry. 2007;20:42–6. DOI: 10.1097%2FYCO.0b013e328010ddf4.</p><p>Borsook D. Neurological diseases and pain. Brain. 2012:135(2);320–44. DOI: 10.1093%2Fbrain%2Fawr271.</p><p>Fishbain DA, Cutler R, Rosomoff HL. Chronic pain-associated depression: Antecedent or consequence of chronic pain? A review. Clin J Pain. 1997;13(2):116–37. DOI: 10.1097%2F00002508-199706000-00006.</p><p>Fishbain DA, Steele-Rosomoff R, Rosomoff HL. Drug abuse, dependence, and addiction in chronic pain patients. Clin J Pain. 1992;8(2):77–85. DOI: 10.1097%2F00002508-199206000-00003.</p><p>Fishbain DA, Cutler RB, Rosomoff H, Steele-Rosomoff R. Comorbidity between psychiatric disorders and chronic pain. Curr Rev Pain. 1998;2(1):1–10. DOI: 10.1007%2Fs11916-998-0057-7.</p><p>Hollander E. Treatment of obsessive-compulsive spectrum disorders with SSRI. Br J Psychiatry Suppl. 1998;35:7–12.</p><p>Fishbain DA, Cutler RB, Cole B et al. Are patients with chronic low back pain or chronic neck pain fatigued? Pain Med. 2004;5(2):187–95. DOI: 10.1111%2Fj.1526-4637.2004.04026.x.</p><p>Williams AN, Hill P, Gunary R, Gratchley G. Sexual difficulties of chronic pain patients. Clin J Pain. 2001;17:138–45.</p><p>Waddell G, McCulloch JA, Kummel E, Venner RM. Nonorganic physical signs in low-back pain. Spine. 1980;5(2):117–25. DOI: 10.1097%2F00007632-198003000-00005.</p><p>Simuni T, Sethi K. Nonmotor manifestations of Parkinson’s disease. Ann Neurol. 2008;64 Suppl 2:65–80. DOI: 10.1002/ana.21472.</p><p>Goldenberg DL. Pain/depression dyad: a key to a better understanding and treatment of functional somatic syndromes. Am J Med. 2010;123(8):675–82. DOI: 10.1016/j.amjmed.2010.01.014. Epub 2010 Jun 11.</p><p>Stahl SM. Stahl's Essential Psychopharmacology. 3rd ed. Cambridge: University Press; 2008.</p><p>Phillips ML, Drevets WC, Rauch SL, Lane R. Neurobiology of emotion perception I: The neuronal basis of normal emotion perception. Biol Psychiatry. 2003;54(5):504–14.</p><p>Breder CD, Conway CM. Pain systems: interface with the affective brain. Sadock BJ, Sadock AV, editors. Kaplan & Sadock’s Comprehensive textbook of psychiatry. Lippincott Williams & Wilkins; 2009. P. 341–5.</p><p>Strigo IA, Simmons AN, Matthews SC et al. Major depressive disorder is associated with altered functional brain response during anticipation and processing of heat pain. Arch Gen Psychiatry. 2008;65(11):1275–84. DOI: 10.1001/archpsyc.65.11.1275.</p><p>Pittinger C, Durman RS. Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology. 2008;33(1):88–109. DOI: 10.1038%2Fsj.npp.1301574. Epub 2007 Sep 12.</p><p>Videbech P, Ravnklide B. Hippocampal volume and depression: a meta analysis of MRI studies. Am J Psychiatry. 2004;161(11):1957–66. DOI: 10.1176%2Fappi.ajp.161.11.1957.</p><p>Deak T, Bordner KA, McElderry NK et al. Stress-induced increases in hypothalamic IL-1: a systematic comparison of multiple stressor paradigms. Brain Res Bull. 2005;64(6):541–56.</p><p>Kim YK, Na KS, Shin KH et al. Cytokine imbalance in the pathophysiology of major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31(5):1044–53. DOI: 10.1016%2Fj.pnpbp.2007.03.004. Epub 2007 Mar 13.</p><p>Schrocksnadel K, Wirleitner B, Winkler C, Fuchs D. Monitoring tryptophan metabolism in chronic immune activation. Clin Chem Acta. 2006;364(1-2):82–90.DOI: 10.1016%2Fj.cca.2005.06.013. Epub 2005 Sep 1.</p><p>Arnow BA. Relationships between childhood maltreatment, adult health and psychiatric outcomes, and medical utilization. J Clin Psychiatry. 2004;65 suppl 12:10–5.</p><p>Greden JF. Physical symptoms of depression: unmet needs. J Clin Psychiatry. 2003;64 suppl 7:5–11.</p><p>Chan HN, Fam J, Ng BY. Use of Antidepressants in the Treatment of Chronic Pain. Ann Acad Med Singapore. 2009;38(11):974–9.</p><p>Ettinger AB, Argoff CE. Use of antiepileptic drugs for nonepileptic conditions: psychiatric disorders and chronic pain. Neurotherapeutics. 2007;4(1):75–83. DOI: 10.1016%2Fj.nurt.2006.10.003.</p><p>Mercier A, Auger-Aubin I, Lebeau JP et al. Evidence of prescription of antidepressants for non-psychiatric conditions in primary care: an analysis of guidelines and systematic reviews. BMC Family Practice. 2013;14:55. DOI: 10.1186/1471-2296-14-55.</p><p>Larson MJ, Miller K, Fleming KJ. Treatment with antidepressant medications in private health plans. Adm Policy Ment Health. 2007;34(2):116–26. DOI: 10.1007%2Fs10488-006-0088-5.</p><p>Bras M, Dordevic V, Gregurek R, Bulajic M. Neurobiological and clinical relationship between psychiatric disorders and chronic pain. Psychiatr Danub. 2010;22(2):221–26.</p><p>Leuchter AF, Husain MM, Cook IA et al. Painful physical symptoms and treatment outcome in major depressive disorder: a STAR*D (Sequenced Treatment Alternatives to Relive Depression) report. Psychol Med. 2010;40(2):239–51. doi: 10.1017/S0033291709006035. Epub 2009 Jun 3.</p><p>Fishbain DA. Evidence-based treatment paradigms for depressed patients with pain and physical symptoms. J Clin Psychiatry. 2009;70(7):e22. DOI: 10.4088%2FJCP.8001tx4c.</p><p>Marks DM, Shah MJ, Patkar AA et al. Serotonin-norepinephrine reaptake inhibitors for pain control: premise and promise. Curr Neuropharmacology. 2009;7(4):331–6. DOI: 10.2174/157015909790031201.</p><p>Белова НА. Эсциталопрам (ципралекс) в общей медицине (обзор литературы). Consilium Medicum. 2010;(2):52–4. [Belova NA. Estsitalopram (tsipraleks) v obshchey meditsine (obzor literatury). Consilium Medicum. 2010;(2):52–4.]</p><p>Незнанов НГ, Борцов АВ. Новое качество терапии расстройств тревожно-депрессивного спектра – эсциталопрам. Журнал неврологии и психиатрии им. С.С.Корсакова. 2005;105(2):79–84. [Neznanov NG, Bortsov AV. A new quality of the therapy of anxiety and depression – escitalopram. Neuroscience and Behavioral Physiology. 2005;105(2):79–84.]</p><p>Chen F, Larsen MB, Sanchez C, Wiborg O. The S-enantiomer of R,S-citalopram, increases inhibitor binding to the human serotonin transporter by an allosteric mechanism. Comparison with other serotonin transporter inhibitors. Eur Neuropsychopharmacol. 2005;15(2):193–8. DOI: 10.1016%2Fj.euroneuro.2004.08.008.</p><p>Wade A, Lemming MO, Hedegaard BK. Escitalopram 10 mg/day is effective and well tolerated in a placebo-controlled study in depression in primary care. Int Clin Psychopharmacol. 2002;17(3):95–102. DOI: 10.1097%2F00004850-200205000-00001.</p><p>Montgomery S, Hansen T, Kasper S. Efficacy of escitalopram compared to citalopram: a meta-analysis. Int J Neuropsychopharmacol. 2011;14(2):261–68. DOI: 10.1017/S146114571000115X. Epub 2010 Sep 29.</p><p>Kennedy SH, Andersen HF, Thase ME. Escitalopram in the treatment of major depressive disorder: a meta-analysis. Curr Med Res Opin. 2009;25(1):161–75. DOI: 10.1185/03007990802622726.</p><p>Kirino E. Escitalopram for the management of major depressive disorder: a review of its efficacy, safety, and patient acceptability. Patient Prefer Adherence. 2012;6:853–61. DOI: 10.2147/PPA.S22495. Epub 2012 Dec 4.</p><p>Mazza M, Mazza O, Pazzaglia C et al. Escitalopram 20 mg versus duloxetine 60 mg for the treatment of chronic low back pain. Expert Opin Pharmacother. 2010;11(7):1049–52. DOI: 10.1517/14656561003730413.</p></div><br />
Рецензия
Для цитирования:
Tabeeva GR. Коморбидность хронической боли и депрессии у неврологических больных. Неврология, нейропсихиатрия, психосоматика. 2013;5(3):4-12. https://doi.org/10.14412/2074-2711-2013-2332
For citation:
Tabeeva GR. Comorbidity of chronic pain and depression in neurological patients. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2013;5(3):4-12. (In Russ.) https://doi.org/10.14412/2074-2711-2013-2332